Communications
News & Press Release
-
"Wigobi there"...BioVenture Speeds Research on Native Obesity Drugs.2024.03.26
-
Kim Sang-wook, CEO of Neurobiogen, said, "We will promote the transfer of technology and treatment for dementia and obesity".2024.03.20
-
Neurobiogen "Phase 1 successful treatment for obesity and dementia...Application for Phase 2 of Q2".2024.03.20
-
Neurobiogen, obesity treatment..."It's more effective and safer" than the mainstream GLP-1.2024.03.20
-
Neurobiogen Succeeds in Phase 1 Clinical Trials for Dementia and Obesity Drugs..."Nothing is wrong with financing".2024.03.20